LobbyingEmergent Biosolutions lobbying by quarter
Emergent Biosolutions EBS's latest lobbying report covers Q2 2026, at $670K. The four quarters Q4 2025–Q3 2026 total $2.2M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Emergent BiosolutionsEBS
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $1M | 10 |
| Q1 2023 | $1.3M | 10 |
| Q2 2023 | $1.2M | 11 |
| Q3 2023 | $845K | 12 |
| Q4 2023 | $875K | 10 |
| Q1 2024 | $1.1M | 10 |
| Q2 2024 | $835K | 10 |
| Q3 2024 | $835K | 10 |
| Q4 2024 | $920K | 7 |
| Q1 2025 | $1.1M | 5 |
| Q2 2025 | $630K | 5 |
| Q3 2025 | $720K | 5 |
| Q4 2025 | $620K | 5 |
| Q1 2026 | $890K | 4 |
| Q2 2026 | $670K | 4 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$4.3M · 98 reports
- Disaster planning and emergencies$3.1M · 62 reports
- Budget and appropriations$3M · 72 reports
- Homeland security$2.6M · 45 reports
- Aviation and airlines$319K · 16 reports
- Defense$170.7K · 19 reports
- Aerospace$57.3K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES106 reports
- SENATE100 reports
- Health & Human Services, Dept of (HHS)31 reports
- White House Office25 reports
- Office of Natl Drug Control Policy (NDCP)19 reports
- Office of Management & Budget (OMB)15 reports
- Substance Abuse & Mental Health Services Administration (SAMHSA)10 reports
- Office of Administration7 reports
- Food & Drug Administration (FDA)6 reports
- Centers For Disease Control & Prevention (CDC)4 reports
- Homeland Security, Dept of (DHS)4 reports
- Justice, Dept of (DOJ)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseEmergent Biosolutions | $9.1M | 15 quarters |
| Capitol Counsel | $750K | 15 quarters |
| CGCN Group | $665K | 13 quarters |
| Alpine Group Partners | $650K | 13 quarters |
| The Nickles Group | $600K | 15 quarters |
| Ervin Graves Strategy Group | $450K | 9 quarters |
| Navigators Global | $430K | 9 quarters |
| Mercury Public Affairs | $365K | 8 quarters |
| Forbes-Tate | $200K | 4 quarters |
| The Ob-C Group | $160K | 8 quarters |
| Hecht Latham Spencer & Associates, Inc., Formerly Known As Hecht Spencer & Assoc | $140K | 8 quarters |
| Todd Strategy Group | $0 | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KAREN STONE | Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY). | Q1 2026 |
| ERIN MENDELSOHN | LD, Rep. Anna Eshoo; Congressional Liaison - FDA | Q4 2025 |
| HANNAH SCHMIDT | Professional Staff, House Small Business Cmte | Q4 2025 |
| KEENAN AUSTIN REED | Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson | Q4 2024 |
| SHAYNE WOODS | Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus Bilirakis | Q4 2024 |
| DAVID HEIL | Congressman Sam Johnson | Q3 2024 |
| MATTHEW MARSH | N/A | Q1 2024 |
| GREG D'ANGELO | White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member | Q3 2023 |
| MARY BETH SAVARY TAYLOR | Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant | Q3 2023 |
| DANIEL SAUERS | N/A | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | CGCN Group | $70K |
| 07/15for Q2 | The Nickles Group | $40K |
| 07/14for Q2 | In-house | $510K |
| 07/08for Q2 | Capitol Counsel | $50K |
| 04/20for Q1 | CGCN Group | $70K |
| 04/15for Q1 | Capitol Counsel | $50K |
| 04/15for Q1 | The Nickles Group | $40K |
| 04/14for Q1 | In-house | $730K |
| 01/20for Q4 2025 | CGCN Group | $50K |
| 01/20for Q4 2025 | The Nickles Group | $40K |
| 01/18for Q4 2025 | Capitol Counsel | $50K |
| 01/17for Q4 2025 | Alpine Group Partners | $50K |
| 01/16for Q4 2025 | In-house | $430K |
| 25/10/20for Q3 2025 | The Nickles Group | $40K |
| 25/10/19for Q3 2025 | CGCN Group | $50K |
| 25/10/18for Q3 2025 | Alpine Group Partners | $50K |
| 25/10/15for Q3 2025 | Capitol Counsel | $50K |
| 25/10/15for Q3 2025 | In-house | $530K |
| 25/07/21for Q2 2025 | CGCN Group | $50K |
| 25/07/19for Q2 2025 | Alpine Group Partners | $50K |